$592 Million is the total value of SECTOR GAMMA AS's 34 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 17.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $70,321,000 | +14.7% | 1,386,722 | +2.6% | 11.88% | +20.6% |
| BSX | BOSTON SCIENTIFIC CORP | $45,098,000 | -5.3% | 1,108,336 | 0.0% | 7.62% | -0.5% | |
| ABT | Sell | ABBOTT LABS | $44,953,000 | -22.2% | 537,260 | -21.8% | 7.60% | -18.3% |
| BAX | Buy | BAXTER INTL INC | $41,313,000 | +9.1% | 472,305 | +2.2% | 6.98% | +14.7% |
| GILD | Buy | GILEAD SCIENCES INC | $30,109,000 | +0.1% | 475,056 | +6.7% | 5.09% | +5.3% |
| NUVA | Sell | NUVASIVE INC | $29,678,000 | +1.5% | 468,258 | -6.2% | 5.01% | +6.7% |
| INCY | Buy | INCYTE CORP | $25,676,000 | -3.7% | 345,893 | +10.2% | 4.34% | +1.2% |
| PKI | PERKINELMER INC | $25,568,000 | -11.6% | 300,198 | 0.0% | 4.32% | -7.1% | |
| REGN | Buy | REGENERON PHARMACEUTICALS | $21,037,000 | +16.6% | 75,835 | +31.6% | 3.55% | +22.6% |
| A | Sell | AGILENT TECHNOLOGIES INC | $19,946,000 | -7.6% | 260,293 | -10.0% | 3.37% | -2.9% |
| ANTM | Buy | ANTHEM INC | $17,913,000 | -13.2% | 74,607 | +2.1% | 3.03% | -8.7% |
| LLY | New | LILLY ELI & CO | $17,010,000 | – | 152,105 | +100.0% | 2.87% | – |
| QGEN | Buy | QIAGEN NV | $15,977,000 | -7.0% | 484,601 | +14.4% | 2.70% | -2.2% |
| BIO | Sell | BIO RAD LABS INCcl a | $15,428,000 | -42.0% | 46,368 | -45.5% | 2.61% | -39.0% |
| PRGO | Sell | PERRIGO CO PLC | $14,411,000 | +8.9% | 257,844 | -7.2% | 2.44% | +14.5% |
| TAK | Buy | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $14,040,000 | -0.4% | 816,299 | +2.5% | 2.37% | +4.7% |
| BRKR | Buy | BRUKER CORP | $13,531,000 | +21.5% | 308,004 | +38.1% | 2.29% | +27.7% |
| BIIB | Sell | BIOGEN INC | $12,206,000 | -54.7% | 52,426 | -54.5% | 2.06% | -52.4% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $11,815,000 | – | 148,147 | +100.0% | 2.00% | – |
| HUM | Sell | HUMANA INC | $11,249,000 | -36.6% | 43,999 | -34.2% | 1.90% | -33.4% |
| ELAN | Buy | ELANCO ANIMAL HEALTH INC | $11,089,000 | +77.3% | 417,042 | +125.4% | 1.87% | +86.5% |
| UHS | UNIVERSAL HLTH SVCS INCcl b | $9,630,000 | +14.1% | 64,742 | 0.0% | 1.63% | +19.9% | |
| THC | Buy | TENET HEALTHCARE CORP | $9,504,000 | +40.0% | 429,677 | +30.7% | 1.61% | +47.2% |
| CAH | CARDINAL HEALTH INC | $9,311,000 | +0.2% | 197,299 | 0.0% | 1.57% | +5.3% | |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $8,811,000 | – | 89,964 | +100.0% | 1.49% | – |
| PDCO | PATTERSON COMPANIES INC | $8,362,000 | -22.2% | 469,255 | 0.0% | 1.41% | -18.2% | |
| IONS | IONIS PHARMACEUTICALS INC | $7,879,000 | -6.8% | 131,514 | 0.0% | 1.33% | -2.1% | |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $7,793,000 | +49.4% | 96,900 | +34.8% | 1.32% | +57.0% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $7,400,000 | +46.3% | 172,978 | +117.2% | 1.25% | +53.8% |
| PTCT | Sell | PTC THERAPEUTICS INC | $4,106,000 | -60.2% | 121,402 | -47.1% | 0.69% | -58.2% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $3,377,000 | -39.0% | 125,925 | -38.2% | 0.57% | -35.8% |
| AGIO | AGIOS PHARMACEUTICALS INC | $3,334,000 | -35.0% | 102,913 | 0.0% | 0.56% | -31.8% | |
| SGMO | SANGAMO THERAPEUTICS INC | $2,278,000 | -16.0% | 251,698 | 0.0% | 0.38% | -11.7% | |
| CLVS | CLOVIS ONCOLOGY INC | $1,696,000 | -73.6% | 431,425 | 0.0% | 0.29% | -72.2% | |
| MCK | Exit | MCKESSON CORP | $0 | – | -44,175 | -100.0% | -0.95% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -175,743 | -100.0% | -1.54% | – |
| MYL | Exit | MYLAN N V | $0 | – | -504,592 | -100.0% | -1.54% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.